BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 1463119)

  • 1. Prognostic factors in differentiated carcinoma of the thyroid gland.
    Shah JP; Loree TR; Dharker D; Strong EW; Begg C; Vlamis V
    Am J Surg; 1992 Dec; 164(6):658-61. PubMed ID: 1463119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical treatment of papillary and follicular thyroid carcinoma.
    Lin JD; Jeng LB; Chao TC; Weng HF; Huang HS
    Int Surg; 1996; 81(1):61-6. PubMed ID: 8803709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.
    Mazzaferri EL; Jhiang SM
    Am J Med; 1994 Nov; 97(5):418-28. PubMed ID: 7977430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histology does not influence prognosis in differentiated thyroid carcinoma when accounting for age, tumour diameter, invasive growth and metastases.
    Verburg FA; Mäder U; Luster M; Reiners C
    Eur J Endocrinol; 2009 Apr; 160(4):619-24. PubMed ID: 19158232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in follicular carcinoma of the thyroid: a study of 198 cases.
    Rao RS; Parikh HK; Deshmane VH; Parikh DM; Shrikhande SS; Havaldar R
    Head Neck; 1996; 18(2):118-24; discussion 124-6. PubMed ID: 8647676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region.
    Passler C; Scheuba C; Prager G; Kaczirek K; Kaserer K; Zettinig G; Niederle B
    Endocr Relat Cancer; 2004 Mar; 11(1):131-9. PubMed ID: 15027890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk group stratification and prognostic factors in papillary carcinoma of thyroid.
    Shaha AR; Shah JP; Loree TR
    Ann Surg Oncol; 1996 Nov; 3(6):534-8. PubMed ID: 8915484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of nodal and distant metastasis based on histologic varieties in differentiated carcinoma of the thyroid.
    Shaha AR; Shah JP; Loree TR
    Am J Surg; 1996 Dec; 172(6):692-4. PubMed ID: 8988680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.
    Haq M; Harmer C
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multivariate analysis of survival in differentiated thyroid cancer: the prognostic significance of the age factor.
    Schelfhout LJ; Creutzberg CL; Hamming JF; Fleuren GJ; Smeenk D; Hermans J; van de Velde CJ; Goslings BM
    Eur J Cancer Clin Oncol; 1988 Feb; 24(2):331-7. PubMed ID: 3356216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of cervical lymph node metastases in differentiated thyroid cancer.
    Sellers M; Beenken S; Blankenship A; Soong SJ; Turbat-Herrera E; Urist M; Maddox W
    Am J Surg; 1992 Dec; 164(6):578-81. PubMed ID: 1463103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH; Shen WT; Gosnell J; Duh QY
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors associated with differentiated thyroid cancer.
    Tsuchiya A; Suzuki S; Kanno M; Kikuchi Y; Ando Y; Abe R
    Surg Today; 1995; 25(9):778-82. PubMed ID: 8555694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis.
    Hughes CJ; Shaha AR; Shah JP; Loree TR
    Head Neck; 1996; 18(2):127-32. PubMed ID: 8647677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Poorly differentiated thyroid follicular carcinoma - a clinical analysis of 30 cases].
    Liu WS; Qi YF; Tang PZ
    Ai Zheng; 2004 Sep; 23(9):1081-4. PubMed ID: 15363207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
    Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
    Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid carcinomas with distant metastases: a review of 111 cases with emphasis on the prognostic significance of an insular component.
    Decaussin M; Bernard MH; Adeleine P; Treilleux I; Peix JL; Pugeat M; Tourniaire J; Berger N
    Am J Surg Pathol; 2002 Aug; 26(8):1007-15. PubMed ID: 12170087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncoproteins and tumor progression in papillary thyroid carcinoma: presence of epidermal growth factor receptor, c-erbB-2 protein, estrogen receptor related protein, p21-ras protein, and proliferation indicators in relation to tumor recurrences and patient survival.
    Akslen LA; Varhaug JE
    Cancer; 1995 Nov; 76(9):1643-54. PubMed ID: 8635070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases.
    Lin JD; Huang MJ; Juang JH; Chao TC; Huang BY; Chen KW; Chen JY; Li KL; Chen JF; Ho YS
    Thyroid; 1999 Dec; 9(12):1227-35. PubMed ID: 10646663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.